Cellectis

Cellectis

Cellectis

Cellectis is a biopharmaceutical company. The company’s mission is to develop a novel generation of therapy based on allogeneic T-cells to treat cancer.
Founded
1999
Raised
$14.1M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$6,913,608
Venture capital (Series C) - 2005
$7,223,476
Venture capital (Series B) - 2002
Team Size
50+
Employees
Location
Headquarters
MedCity News

Cellectis publishes description of new 'all-in-one' CAR-T architecture